Skip to main content

Table 1 Characteristics and outcomes of 23 patients with malignant pelvic tumors

From: New adjustable modular hemipelvic prosthesis replacement with 3D-print osteotomy guide plate used in periacetabular malignant tumors: a retrospective case series

Case

Gender

Age

Reconstruction methods

Surgical margin

Pathological diagnosis

Stage

Resection type

Intervention operation

Blood loss (ml)

Complications

LLD(cm)

Follow-up (months)

MSTS score

Harris score

Recurrence metastasis

Patient status

1

Male

54

NAHP

Wide

Angiosarcoma

IIB

I + II

YES

1200

Infection

1

21

20

80

Recurrence

DOD

2

Male

65

NAHP

Wide

Metastatic lung adenocarcinoma

III

II + III

YES

1400

 

1

26

17

66

 

AWD

3

Male

46

NAHP

Marginal

Angiosarcoma

IIB

I + II

YES

2500

Pulmonary

1.5

27

19

77

 

NED

4

Female

53

NAHP

Wide

Chondrosarcoma

IIB

I + II

YES

1200

Infection

1

23

23

83

 

NED

5

Female

56

NAHP

Wide

Mesenchymal malignancy

IIB

I + II

YES

1000

 

1

21

22

85

 

NED

6

Female

38

MHP

Marginal

mesenchymal malignancy

IIB

I + II + III

NO

2000

Cutaneous necrosis

1.5

20

15

57

Lung Metastasis

DOD

7

Male

33

MHP

Wide

MGCT

IIB

II

NO

1500

 

1

58

23

87

 

NED

8

Female

51

MHP

Wide

Chondrosarcoma

IIB

II + III

NO

2600

 

1

19

19

76

Recurrence

DOD

9

Male

35

MHP

Marginal

MGCT

IIB

II + III

NO

3200

 

2

46

14

53

 

NED

10

Male

28

MHP

Wide

Synovial sarcoma

IIB

I + II + III

NO

2100

Dislocation

2.5

52

22

84

 

NED

11

Male

34

MHP

Wide

Invasive chondroblastoma

IIB

II + III

NO

5000

Wound dehiscence

2

45

20

77

 

NED

12

Female

45

MHP

Wide

Chondrosarcoma

IIB

II + III

NO

4800

Wound dehiscence

1

26

18

73

 

NED

13

Female

27

MHP

Wide

Chondrosarcoma

IIB

II + III

NO

2700

 

1.5

28

18

76

 

NED

14

Female

50

MHP

Wide

Chondrosarcoma

IIB

II + III

NO

2500

 

1

19

21

83

 

NED

15

Male

45

MHP

Wide

MGCT

IIB

I + II + III

NO

8000

Infection

NA

36

10

56

 

NED

          

Tension blisters

      
          

HA

      

16

Male

37

MHP

Wide

fibrosarcoma

IIB

I + II

NO

5000

 

1

37

23

85

 

NED

17

Male

45

MHP

Wide

MGCT

IIB

II + III

YES

2300

 

1.5

47

20

78

 

NED

18

Male

48

S-RHP

Marginal

Angiosarcoma

IIB

I + II

NO

3200

Infection

1

26

18

75

Recurrence

DOD

19

Male

57

S-RHP

Wide

Chondrosarcoma

IIB

I + II

NO

3700

Wound dehiscence

1.5

25

14

56

 

NED

20

Male

75

S-RHP

Marginal

chondrosarcoma

IIB

I + II

YES

3000

Infection

2

18

17

72

Recurrence

DOD

          

Dislocation

    

Lung Metastasis

 
          

Urinary retention

      
          

Thrombosis

      

21

Male

61

S-RHP

Wide

chondrosarcoma

IIB

I + II

NO

2600

Dislocation

1

20

15

61

Recurrence

DOD

22

Female

21

S-RHP

Wide

chondrosarcoma

IB

I + II

NO

1200

 

1.5

38

19

80

 

NED

23

Male

21

S-RHP

Wide

osteosarcoma

IIB

I + II

NO

2000

 

1.5

21

20

76

Recurrence

DOD

               

Lung Metastasis

 
  1. NAHP: new adjustable modular hemipelvic prosthesis, MHP: modular hemipelvic prosthesis, S-RHP: screw-rod hemipelvic prosthesis, MGCT: malignant giant cell tumor,
  2. HA: hip amputation, NED: no evidence of disease, DOD: died of disease, AWD: alive with disease, NA: not available, MSTS: Musculoskeletal Tumor Society